Web Results

Gemtuzumab ozogamicin

en.wikipedia.org/wiki/Gemtuzumab_ozogamicin

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody- drug conjugate) that was used to treat acute myelogenous leukemia from 2000 to  ...

Gemtuzumab Ozogamicin - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/gemtuzumabozogamicin

This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ...

Gemtuzumab ozogamicin (Mylotarg®; Pfizer/Wyeth) ADC Review

adcreview.com/gemtuzumab-ozogamicin-mylotarg/

Jul 19, 2015 ... Gemtuzumab ozogamicin (Mylotarg®; Pfizer/Wyeth-Ayerst Laboratories) is a recombinant, humanized anti-CD33 monoclonal antibody (IgG4 κ ...

Gemtuzumab Ozogamicin: Time to Resurrect?

jco.ascopubs.org/content/30/32/3921.full

Nov 10, 2012 ... On May 17, 2000, the US Food and Drug Administration (FDA) granted accelerated approval for the use of gemtuzumab ozogamicin (GO) in ...

Safety Alerts for Human Medical Products > Mylotarg (gemtuzumab ...

www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216458.htm

Mylotarg (gemtuzumab ozogamicin): Market Withdrawal. Audience: Oncology, Hematology. [Posted 06/21/2010]. ISSUE: FDA notified healthcare professionals  ...

Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable ...

www.ncbi.nlm.nih.gov/pubmed/23591788

Blood. 2013 Jun 13;121(24):4838-41. doi: 10.1182/blood-2013-03-490482. Epub 2013 Apr 16. Gemtuzumab ozogamicin in acute myeloid leukemia: a ...

Gemtuzumab (Mylotarg®) - Cancer Information - Macmillan Cancer ...

www.macmillan.org.uk/cancerinformation/cancertreatment/treatmenttypes/biologicaltherapies/monoclonalantibodies/gemtuzumab.aspx

Information about the monoclonal antibody gemtuzumab (Mylotarg®), which is mainly used as part of research trials to treat some types of acute myeloid ...

Mylotarg - Pfizer

labeling.pfizer.com/showlabeling.aspx?id=119

Mylotarg® (gemtuzumab ozogamicin for Injection) is a chemotherapy agent composed of a recombinant humanized IgG4, kappa antibody conjugated with a  ...

Mylotarg - FDA prescribing information, side effects and uses

www.drugs.com/pro/mylotarg.html

Mylotarg® (gemtuzumab ozogamicin for Injection) is a chemotherapy agent composed of a recombinant humanized IgG4, kappa antibody conjugated with a  ...

Approval summary: gemtuzumab ozogamicin in relapsed acute ...

www.ncbi.nlm.nih.gov/pubmed/11410481

PURPOSE: Gemtuzumab ozogamicin (Mylotarg; Wyeth Laboratories, Philadelphia, PA) consists of a semisynthetic derivative of calicheamicin, a cytotoxic ...

More Info

Gemtuzumab Ozogamicin - Drug Information - Chemocare

chemocare.com

Mylotarg is the trade name for gemtuzumab ozogamicin. In some cases, health care professionals may use the trade name mylotarg when referring to the ...

Blood Journal | Gemtuzumab ozogamicin in acute myeloid leukemia ...

www.bloodjournal.org

Jun 13, 2013 ... Gemtuzumab ozogamicin (GO) consists of a humanized anti-CD33 monoclonal antibody conjugated with calicheamicin, a potent antitumor ...

About the Center for Drug Evaluation and Research > Gemtuzumab ...

www.fda.gov

Nov 27, 2015 ... On June 21, 2010, Pfizer Inc., in agreement with the FDA, announced that the commercial marketing of Mylotarg (gemtuzumab ozogamicin) will ...